Antibodies are neutralizing, meaning that they prevent the virus from being infectious, and can thus be used to treat viral diseases. Two of the antibodies, b38 and h4, blocked the receptor binding domain (rbd) of viral spike protein from binding to a patient’s receptor-binding domain…
Read more at Science…
